Global Mental Health Market

Mental Health Market Size, Share, Growth Analysis, By Application(Physiological Disorder(Depression, Anxiety, Post-Traumatic Stress Disorder (PTSD), Bipolar Disorder), By By Technology(Self-Screening Mental Health Apps, Telehealth And virtual Care Solutions, Continuous Monitoring Wearable Devices, AI Based Screening Tools), By Age Group(Children And Adolescents, Adults, Seniors), By Setting(Clinical Setting, Educational Institutions, Workspace Slash Corporate Programs, Online Platforms), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2233 | Region: Global | Published Date: August, 2024
Pages: 219 | Tables: 65 | Figures: 75

Mental Health Market Competitive Landscape

Mental health providers should focus on creating campaigns and working with public health organizations and governments to improve awareness regarding mental health. Incorporating telemedicine and telehealth practices for mental health will be crucial in determining the success of any mental health company operating in this market. Mental health mobile applications are projected to bring in substantial revenue for mental health companies in the long run. 

Top Player’s Company Profiles in Global Mental Health Market

  • Pfizer Inc. (US) 
  • Johnson & Johnson (US) 
  • Eli Lilly and Company (US) 
  • Bristol-Myers Squibb (US) 
  • GlaxoSmithKline (UK) 
  • AstraZeneca (UK) 
  • Merck & Co., Inc. (US) 
  • Takeda Pharmaceutical Company Limited (Japan) 
  • Otsuka Holdings Co., Ltd. (Japan) 
  • Novartis International AG (Switzerland) 
  • Sanofi S.A. (France) 
  • Lundbeck A/S (Denmark) 
  • Teva Pharmaceutical Industries Ltd. (Israel) 
  • AbbVie Inc. (US) 
  • Boehringer Ingelheim International GmbH (Germany) 
  • H. Lundbeck A/S (Denmark) 
  • Sun Pharmaceutical Industries Ltd. (India) 
  • Alkermes plc (Ireland) 
  • Amgen Inc. (US) 
  • Gilead Sciences, Inc. (US) 
  • Hikma Pharmaceuticals PLC (UK) 
  • Jazz Pharmaceuticals plc (Ireland) 

Global Mental Health Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Mental Health Market size was valued at USD 399.61 billion in 2022 and is poised to grow from USD 413.60 billion in 2023 to USD 544.63 billion by 2031, at a CAGR of 3.5% during the forecast period (2024-2031). 

Mental health providers should focus on creating campaigns and working with public health organizations and governments to improve awareness regarding mental health. Incorporating telemedicine and telehealth practices for mental health will be crucial in determining the success of any mental health company operating in this market. Mental health mobile applications are projected to bring in substantial revenue for mental health companies in the long run.  'Pfizer Inc. (US) ', 'Johnson & Johnson (US) ', 'Eli Lilly and Company (US) ', 'Bristol-Myers Squibb (US) ', 'GlaxoSmithKline (UK) ', 'AstraZeneca (UK) ', 'Merck & Co., Inc. (US) ', 'Takeda Pharmaceutical Company Limited (Japan) ', 'Otsuka Holdings Co., Ltd. (Japan) ', 'Novartis International AG (Switzerland) ', 'Sanofi S.A. (France) ', 'Lundbeck A/S (Denmark) ', 'Teva Pharmaceutical Industries Ltd. (Israel) ', 'AbbVie Inc. (US) ', 'Boehringer Ingelheim International GmbH (Germany) ', 'H. Lundbeck A/S (Denmark) ', 'Sun Pharmaceutical Industries Ltd. (India) ', 'Alkermes plc (Ireland) ', 'Amgen Inc. (US) ', 'Gilead Sciences, Inc. (US) ', 'Hikma Pharmaceuticals PLC (UK) ', 'Jazz Pharmaceuticals plc (Ireland) '

People have become more aware of the importance of mental health owing to efforts of non-profit organizations and governments. This surge in awareness regarding mental health around the world is projected to bolster the demand for mental health solutions and services going forward.   

Digital Mental Health Apps: Mental health companies can focus on the development of novel mental health applications that can help people detect, manage, or treat their mental health disorders. Moreover, this can improve the accessibility to mental health care for more people than ever before and boost revenue generation as well.  

Growing awareness regarding mental health and increasing emphasis on improving mental health of individuals are projected to help North America dominate the global market growth. Rising consciousness about the importance of mental health, growing availability of mental health care, and rising acceptance of the same are slated to bolster the demand for mental health in the future. Canada and the United States will remain the most opportune markets for mental health companies in this region. A growing geriatric population will also play a crucial role in augmenting mental health demand.  

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Mental Health Market

Report ID: SQMIG35A2233

$5,300
BUY NOW GET FREE SAMPLE